Publications

You can use the filters to show only results that match your interests

Filter publications
169 publications by Advisory Council on the Misuse of Drugs ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Methiopropamine: a review of the evidence of use and harm

    • ACMD
    • Corporate report
  2. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

    • ACMD
    • Policy paper
  3. ACMD members' register of interests

    • ACMD
    • Corporate report
  4. Further advice on U-47,700, etizolam and other designer benzodiazepines

    • Home Office and ACMD
    • Correspondence
  5. Prescribing of controlled drugs by therapeutic radiographers: further advice

    • ACMD
    • Correspondence
  6. Advice on U-47,700, etizolam and other designer benzodiazepines

    • ACMD
    • Correspondence
  7. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • ACMD
    • Correspondence
  8. Misuse of Drugs Regulations 2001: impact on research

    • ACMD
    • Correspondence
  9. Plant cannabinoids: ACMD report

    • ACMD
    • Policy paper
  10. Diversion & illicit supply of medicines

    • ACMD
    • Policy paper
  11. Reducing opioid-related deaths in the UK

    • ACMD
    • Independent report
  12. 'Third generation' synthetic cannabinoids

    • ACMD
    • Correspondence
  13. Temporary class drug order on methiopropamine

    • ACMD
    • Correspondence
  14. Problems for Ageing Drug Users Working Group: public meeting invitation

    • ACMD
    • Promotional material
  15. Independent prescribing of controlled drugs by therapeutic radiographers

    • ACMD
    • Correspondence
  16. ACMD work programme for 2016

    • ACMD
    • Correspondence
  17. ACMD review of alkyl nitrites (poppers)

    • ACMD
    • Correspondence
  18. Advice on the anticonvulsant drugs Pregabalin and Gabapentin

    • ACMD
    • Correspondence
  19. Advice on the steroid Dienedione

    • ACMD
    • Correspondence
  20. ACMD’s temporary class drug order report on Methiopropamine

    • ACMD
    • Correspondence
  21. ACMD public meeting: 24 November 2015

    • ACMD
    • Form
  22. ACMD’s final advice on definitions for the Psychoactive Substances Bill

    • ACMD
    • Correspondence
  23. How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?

    • ACMD
    • Policy paper
  24. Ministerial response to ACMD report on cocaine misuse

    • DH, Home Office and ACMD
    • Correspondence
  25. Ministerial response to ACMD report on nitrous oxide misuse

    • DH, Home Office and ACMD
    • Correspondence
  26. ACMD interim advice: diversion and illicit supply of medicines

    • ACMD
    • Correspondence
  27. ACMD advice about Northern Ireland’s continued maintenance of the Addicts Index

    • ACMD
    • Correspondence
  28. ACMD report on definitions for the Psychoactive Substances Bill

    • ACMD
    • Correspondence
  29. ACMD letter to the Home Secretary: Psychoactive Substances Bill, 13 July 2015

    • ACMD
    • Correspondence
  30. ACMD letter to the Home Secretary: Psychoactive Substances Bill

    • ACMD
    • Correspondence
  31. Letter to Mike Penning on methylphenidate-based novel psychoactive substances

    • ACMD
    • Correspondence
  32. ACMD open meeting registration form: 2 July 2015

    • ACMD
    • Form
  33. Proposals to review and amend specific provisions under the Misuse of Drugs Regulations 2001

    • ACMD
    • Correspondence
  34. Electronic prescribing service for schedules 2 and 3 controlled drugs

    • ACMD
    • Correspondence
  35. Consolidation of the Misuse of Drugs (Designation) Order 2001

    • Home Office and ACMD
    • Correspondence
  36. Cocaine powder: review of its prevalence, patterns of use and harm

    • ACMD
    • Policy paper
  37. Proposal to consolidate the Misuse of Drugs (Designation) Order 2001

    • Home Office and ACMD
    • Correspondence
  38. Advice on 'third generation’ synthetic cannabinoids

    • Home Office and ACMD
    • Correspondence
  39. Rescheduling of ketamine and patient group directions

    • Home Office and ACMD
    • Correspondence
  40. Allied health practitioners independent prescribing

    • Home Office and ACMD
    • Correspondence